Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Field Testing Integrated Interventions for Schistosomiasis Elimination in the People's Republic of China: Outcomes of a Multifactorial Cluster-Randomized Controlled Trial.

Williams GM, Li YS, Gray DJ, Zhao ZY, Harn DA, Shollenberger LM, Li SM, Yu X, Feng Z, Guo JG, Zhou J, Dong YL, Li Y, Guo B, Driguez P, Harvie M, You H, Ross AG, McManus DP.

Front Immunol. 2019 Apr 3;10:645. doi: 10.3389/fimmu.2019.00645. eCollection 2019.

2.

Diagnosis of Schistosoma mansoni infections: what are the choices in Brazilian low-endemic areas?

Silva-Moraes V, Shollenberger LM, Siqueira LMV, Castro-Borges W, Harn DA, Grenfell RFQE, Rabello ALT, Coelho PMZ.

Mem Inst Oswaldo Cruz. 2019 Mar 28;114:e180478. doi: 10.1590/0074-02760180478. Review.

3.

Serological proteomic screening and evaluation of a recombinant egg antigen for the diagnosis of low-intensity Schistosoma mansoni infections in endemic area in Brazil.

Silva-Moraes V, Shollenberger LM, Castro-Borges W, Rabello ALT, Harn DA, Medeiros LCS, Jeremias WJ, Siqueira LMV, Pereira CSS, Pedrosa MLC, Almeida NBF, Almeida A, Lambertucci JR, Carneiro NFF, Coelho PMZ, Grenfell RFQ.

PLoS Negl Trop Dis. 2019 Mar 14;13(3):e0006974. doi: 10.1371/journal.pntd.0006974. eCollection 2019 Mar.

4.

Prime-Boost Vaccine Regimen for SjTPI and SjC23 Schistosome Vaccines, Increases Efficacy in Water Buffalo in a Field Trial in China.

Da'Dara AA, Li C, Yu X, Zheng M, Zhou J, Shollenberger LM, Li YS, Harn DA.

Front Immunol. 2019 Feb 20;10:284. doi: 10.3389/fimmu.2019.00284. eCollection 2019.

5.

Effects of high-fat diet and age on the blood lipidome and circulating endocannabinoids of female C57BL/6 mice.

Pati S, Krishna S, Lee JH, Ross MK, de La Serre CB, Harn DA Jr, Wagner JJ, Filipov NM, Cummings BS.

Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Jan;1863(1):26-39. doi: 10.1016/j.bbalip.2017.09.011. Epub 2017 Oct 4.

PMID:
28986283
6.

Risk of human helminthiases: geospatial distribution and targeted control.

Yu W, Ross AG, Olveda RM, Harn DA, Li Y, Chy D, Williams GM.

Int J Infect Dis. 2017 Feb;55:131-138. doi: 10.1016/j.ijid.2016.12.013. Epub 2016 Dec 14.

7.

A new global strategy for the elimination of schistosomiasis.

Ross AG, Chau TN, Inobaya MT, Olveda RM, Li Y, Harn DA.

Int J Infect Dis. 2017 Jan;54:130-137. doi: 10.1016/j.ijid.2016.09.023. Epub 2016 Dec 12.

8.

Diagnosing schistosomiasis-induced liver morbidity: implications for global control.

Olveda DU, Inobaya M, Olveda RM, Vinluan ML, Ng SK, Weerakoon K, McManus DP, Ramm GA, Harn DA, Li Y, Lam AK, Guevarra JR, Ross AG.

Int J Infect Dis. 2017 Jan;54:138-144. doi: 10.1016/j.ijid.2016.10.024. Epub 2016 Nov 2.

9.

Biennial versus annual treatment for schistosomiasis and its impact on liver morbidity.

Olveda DU, Inobaya MT, McManus DP, Olveda RM, Vinluan ML, Ng SK, Harn DA, Li Y, Guevarra JR, Lam AK, Ross AG.

Int J Infect Dis. 2017 Jan;54:145-149. doi: 10.1016/j.ijid.2016.10.001. Epub 2016 Oct 12.

10.

Risk factors for human helminthiases in rural Philippines.

Ross AG, Olveda RM, McManus DP, Harn DA, Chy D, Li Y, Tallo V, Ng SK.

Int J Infect Dis. 2017 Jan;54:150-155. doi: 10.1016/j.ijid.2016.09.025. Epub 2016 Oct 4.

11.

Neurochemical and electrophysiological deficits in the ventral hippocampus and selective behavioral alterations caused by high-fat diet in female C57BL/6 mice.

Krishna S, Keralapurath MM, Lin Z, Wagner JJ, de La Serre CB, Harn DA, Filipov NM.

Neuroscience. 2015 Jun 25;297:170-81. doi: 10.1016/j.neuroscience.2015.03.068. Epub 2015 Apr 4.

PMID:
25849614
12.

Ex vivo generation of functional immune cells by mitochondria-targeted photosensitization of cancer cells.

Marrache S, Tundup S, Harn DA, Dhar S.

Methods Mol Biol. 2015;1265:113-22. doi: 10.1007/978-1-4939-2288-8_9.

PMID:
25634271
13.

Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice.

Grenfell RF, Shollenberger LM, Samli EF, Harn DA.

Clin Vaccine Immunol. 2015 Mar;22(3):336-43. doi: 10.1128/CVI.00714-14. Epub 2015 Jan 21.

14.

Schistosoma mansoni soluble egg antigens enhance T cell responses to a newly identified HIV-1 Gag H-2b epitope.

Bui CT, Shollenberger LM, Paterson Y, Harn DA.

Clin Vaccine Immunol. 2015 Feb;22(2):193-9. doi: 10.1128/CVI.00514-14. Epub 2014 Dec 17.

15.

Schistosomiasis mass drug administration in the Philippines: lessons learnt and the global implications.

Inobaya MT, Olveda RM, Tallo V, McManus DP, Williams GM, Harn DA, Li Y, Chau TN, Olveda DU, Ross AG.

Microbes Infect. 2015 Jan;17(1):6-15. doi: 10.1016/j.micinf.2014.10.006. Epub 2014 Oct 31. Review.

PMID:
25448635
16.

The chronic enteropathogenic disease schistosomiasis.

Olveda DU, Olveda RM, McManus DP, Cai P, Chau TN, Lam AK, Li Y, Harn DA, Vinluan ML, Ross AG.

Int J Infect Dis. 2014 Nov;28:193-203. doi: 10.1016/j.ijid.2014.07.009. Epub 2014 Sep 20. Review.

17.

Can mass drug administration lead to the sustainable control of schistosomiasis?

Ross AG, Olveda RM, Chy D, Olveda DU, Li Y, Harn DA, Gray DJ, McManus DP, Tallo V, Chau TN, Williams GM.

J Infect Dis. 2015 Jan 15;211(2):283-9. doi: 10.1093/infdis/jiu416. Epub 2014 Jul 28.

PMID:
25070942
18.

Schistosoma mansoni soluble egg antigens enhance Listeria monocytogenes vector HIV-1 vaccine induction of cytotoxic T cells.

Bui CT, Shollenberger LM, Paterson Y, Harn DA.

Clin Vaccine Immunol. 2014 Sep;21(9):1232-9. doi: 10.1128/CVI.00138-14. Epub 2014 Jul 2.

19.

A multi-component integrated approach for the elimination of schistosomiasis in the People's Republic of China: design and baseline results of a 4-year cluster-randomised intervention trial.

Gray DJ, Li YS, Williams GM, Zhao ZY, Harn DA, Li SM, Ren MY, Feng Z, Guo FY, Guo JG, Zhou J, Dong YL, Li Y, Ross AG, McManus DP.

Int J Parasitol. 2014 Aug;44(9):659-68. doi: 10.1016/j.ijpara.2014.05.005. Epub 2014 Jun 11.

PMID:
24929133
20.

Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate.

Pathak RK, Marrache S, Harn DA, Dhar S.

ACS Chem Biol. 2014 May 16;9(5):1178-87. doi: 10.1021/cb400944y. Epub 2014 Mar 25.

21.

Newly established monoclonal antibody diagnostic assays for Schistosoma mansoni direct detection in areas of low endemicity.

Grenfell RF, Coelho PM, Taboada D, de Mattos AC, Davis R, Harn DA.

PLoS One. 2014 Jan 31;9(1):e87777. doi: 10.1371/journal.pone.0087777. eCollection 2014.

22.

The Schistosoma japonicum self-cure phenomenon in water buffaloes: potential impact on the control and elimination of schistosomiasis in China.

Li YS, McManus DP, Lin DD, Williams GM, Harn DA, Ross AG, Feng Z, Gray DJ.

Int J Parasitol. 2014 Mar;44(3-4):167-71. doi: 10.1016/j.ijpara.2013.10.007. Epub 2014 Jan 17. Review.

PMID:
24440417
23.

Bilharzia in the Philippines: past, present, and future.

Olveda DU, Li Y, Olveda RM, Lam AK, McManus DP, Chau TN, Harn DA, Williams GM, Gray DJ, Ross AG.

Int J Infect Dis. 2014 Jan;18:52-6. doi: 10.1016/j.ijid.2013.09.011. Epub 2013 Oct 26. Review.

24.

HIV-1 vaccine-specific responses induced by Listeria vector vaccines are maintained in mice subsequently infected with a model helminth parasite, Schistosoma mansoni.

Shollenberger LM, Bui CT, Paterson Y, Nyhoff L, Harn DA.

Vaccine. 2013 Nov 19;31(48):5651-8. doi: 10.1016/j.vaccine.2013.09.067. Epub 2013 Oct 8.

PMID:
24120546
25.

Road to the elimination of schistosomiasis from Asia: the journey is far from over.

Ross AG, Olveda RM, Acosta L, Harn DA, Chy D, Li Y, Gray DJ, Gordon CA, McManus DP, Williams GM.

Microbes Infect. 2013 Nov;15(13):858-65. doi: 10.1016/j.micinf.2013.07.010. Epub 2013 Aug 23. Review.

26.

Bilharzia: Pathology, Diagnosis, Management and Control.

Olveda DU, Li Y, Olveda RM, Lam AK, Chau TN, Harn DA, Williams GM, Gray DJ, Ross AG.

Trop Med Surg. 2013 Aug 20;1(4). pii: 135.

27.

Ex vivo programming of dendritic cells by mitochondria-targeted nanoparticles to produce interferon-gamma for cancer immunotherapy.

Marrache S, Tundup S, Harn DA, Dhar S.

ACS Nano. 2013 Aug 27;7(8):7392-402. doi: 10.1021/nn403158n. Epub 2013 Aug 6.

PMID:
23899410
28.

New approaches with different types of circulating cathodic antigen for the diagnosis of patients with low Schistosoma mansoni load.

Grenfell R, Harn DA, Tundup S, Da'dara A, Siqueira L, Coelho PM.

PLoS Negl Trop Dis. 2013;7(2):e2054. doi: 10.1371/journal.pntd.0002054. Epub 2013 Feb 28.

29.

Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways.

Bhargava P, Li C, Stanya KJ, Jacobi D, Dai L, Liu S, Gangl MR, Harn DA, Lee CH.

Nat Med. 2012 Nov;18(11):1665-72. doi: 10.1038/nm.2962. Epub 2012 Oct 28.

30.

Polarization of host immune responses by helminth-expressed glycans.

Tundup S, Srivastava L, Harn DA Jr.

Ann N Y Acad Sci. 2012 Apr;1253:E1-E13. doi: 10.1111/j.1749-6632.2012.06618.x. Review.

PMID:
22974465
31.

Immune stimulating photoactive hybrid nanoparticles for metastatic breast cancer.

Marrache S, Choi JH, Tundup S, Zaver D, Harn DA, Dhar S.

Integr Biol (Camb). 2013 Jan;5(1):215-23. doi: 10.1039/c2ib20125a.

32.

Lacto-N-fucopentaose III, a pentasaccharide, prolongs heart transplant survival.

Dutta P, Hullett DA, Roenneburg DA, Torrealba JR, Sollinger HW, Harn DA, Burlingham WJ.

Transplantation. 2010 Nov 27;90(10):1071-8. doi: 10.1097/TP.0b013e3181f8f296.

PMID:
20885339
33.

Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10.

Da'dara AA, Harn DA.

Vaccine. 2010 Feb 3;28(5):1310-7. doi: 10.1016/j.vaccine.2009.11.019. Epub 2009 Nov 24.

34.

Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses.

Wang Y, Da'Dara AA, Thomas PG, Harn DA.

Immunology. 2010 Mar;129(3):406-17. doi: 10.1111/j.1365-2567.2009.03193.x. Epub 2009 Nov 16.

35.

DNA vaccination by electroporation and boosting with recombinant proteins enhances the efficacy of DNA vaccines for Schistosomiasis japonica.

Dai Y, Zhu Y, Harn DA, Wang X, Tang J, Zhao S, Lu F, Guan X.

Clin Vaccine Immunol. 2009 Dec;16(12):1796-803. doi: 10.1128/CVI.00231-09. Epub 2009 Oct 7.

36.

Modulation of host immune responses by helminth glycans.

Harn DA, McDonald J, Atochina O, Da'dara AA.

Immunol Rev. 2009 Jul;230(1):247-57. doi: 10.1111/j.1600-065X.2009.00799.x. Review.

PMID:
19594641
37.

Schistosoma mansoni triose phosphate isomerase peptide MAP4 is able to trigger naïve donor immune response towards a type-1 cytokine profile.

Reis EA, Mauadi Carmo TA, Athanazio R, Reis MG, Harn DA Jr.

Scand J Immunol. 2008 Aug;68(2):169-76. doi: 10.1111/j.1365-3083.2008.02131.x. Epub 2008 Jun 28.

38.

DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo.

Da'dara AA, Li YS, Xiong T, Zhou J, Williams GM, McManus DP, Feng Z, Yu XL, Gray DJ, Harn DA.

Vaccine. 2008 Jul 4;26(29-30):3617-25. doi: 10.1016/j.vaccine.2008.04.080. Epub 2008 May 19.

39.

The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo.

Atochina O, Da'dara AA, Walker M, Harn DA.

Immunology. 2008 Sep;125(1):111-21. doi: 10.1111/j.1365-2567.2008.02826.x. Epub 2008 Mar 28.

40.

Naïve donor responses to Schistosoma mansoni soluble egg antigens.

Reis EA, Azevedo TM, McBride AJ, Harn DA Jr, Reis MG.

Scand J Immunol. 2007 Dec;66(6):662-70.

41.

[Protective effects of co-immunization with SjCTPI-Hsp70 and interleukin-12 DNA vaccines against Schistosoma japonicum challenge infection in water buffalo].

Yu XL, He YK, Xiong T, Zhao YQ, Shi MZ, Zhou J, Liu ZC, Luo XS, Fu X, He HB, Harn DA, Li YS.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2006 Dec;24(6):433-6. Chinese.

PMID:
17366973
42.

Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice.

Da'Dara AA, Lautsch N, Dudek T, Novitsky V, Lee TH, Essex M, Harn DA.

Vaccine. 2006 Jun 12;24(24):5211-9. Epub 2006 Apr 18.

PMID:
16675073
43.

Schistosoma japonicum triose-phosphate isomerase plasmid DNA vaccine protects pigs against challenge infection.

Zhu Y, Si J, Harn DA, Xu M, Ren J, Yu C, Liang Y, Yin X, He W, Cao G.

Parasitology. 2006 Jan;132(Pt 1):67-71.

PMID:
16393355
44.

Comparison of Schistosoma mansoni irradiated cercariae and Sm23 DNA vaccines.

Ganley-Leal LM, Guarner J, Todd CW, Da'Dara AA, Freeman GL Jr, Boyer AE, Harn DA, Secor WE.

Parasite Immunol. 2005 Sep;27(9):341-9.

45.

DNA vaccines against tropical parasitic diseases.

Da'dara AA, Harn DA.

Expert Rev Vaccines. 2005 Aug;4(4):575-89. Review.

PMID:
16117713
46.

A helminth glycan induces APC maturation via alternative NF-kappa B activation independent of I kappa B alpha degradation.

Thomas PG, Carter MR, Da'dara AA, DeSimone TM, Harn DA.

J Immunol. 2005 Aug 15;175(4):2082-90.

47.

[Enhancement of the protective effect of SjC23 DNA vaccine against Schistosoma japonicum infection by immunostimulatory sequence].

Zhao S, Zhu YC, Harn DA, Si J, Ren JG, Yin XR, He W, Liang YS, Xu M, Xu YL.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2005 Feb 28;23(1):1-5. Chinese.

PMID:
16042196
48.

The protective immunity of a DNA vaccine encoding Schistosoma japonicum Chinese strain triose-phosphate isomerase in infected BALB/C mice.

Zhu Y, Si J, Harn DA, Yu C, Liang Y, Ren J, Yin X, He W, Hua W.

Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):518-22.

PMID:
15689059
49.

Protective immunity induced with 23 kDa membrane protein dna vaccine of Schistosoma japonicum Chinese strain in infected C57BL/6 mice.

Zhu Y, Ren J, Harn DA, Si J, Yu C, Ming X, Liang Y.

Southeast Asian J Trop Med Public Health. 2003 Dec;34(4):697-701.

PMID:
15115073
50.

Immune biasing by helminth glycans.

Thomas PG, Harn DA Jr.

Cell Microbiol. 2004 Jan;6(1):13-22. Review.

PMID:
14678327

Supplemental Content

Support Center